Search Results
Results found for "Ross W Cheloha"
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
for the understanding of the cochlea development, hearing disorders, and the treatment for hearing loss In addition, hearing loss can be caused by mutations of certain GPCRs, such as Vlgr1, Gpr156, S1P2, and A1, A2A, and CB2 activation by agonists has protective functions on noise- or drug-induced hearing loss GPCR in the cochlea and discuss the role of GPCR in the cochlea, such as stem cell fate, PCP, hearing loss
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
Nuclear staining with Hoechst ensured that displacement values were not confounded by cell loss or compromised Representative images demonstrated progressive loss of CELT-331 fluorescence (red channel) as concentrations reserve, and internalization are common confounders—access to these images supports more confident cross-series
- Lab Leadership Without Ego: How Sokhom Pin Built the Happiest Team at Alkermes
I was up every night thinking about how to hire, how to lead, how to avoid the mistakes my bad bosses
- The Hidden Operating Cadence That’s Actually Driving Your Biotech
stakeholders ✅ What “good” looks like: A clean, repeatable communication rhythm: internal alignment weekly cross-functional surprises hit harder because the system has no buffer ✅ What “good” looks like: Short, predictable, cross-functional
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
How do we prevent lean muscle loss during weight loss?
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
It’s about finding purpose through loss, choosing academia when many peers walk away, and designing science That personal loss transforms complex receptor pharmacology into something immediate and human.
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
The cross-talk between growth factor receptors and GPCRs is an intriguing area of study. consequences of specific phosphorylation events provide a deeper understanding of the molecular basis for cross-talk
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Novo Nordisk’s amycretin showed up to 24% weight loss, CagriSema delivered 22.7% in Phase 3, and semaglutide
- Diversification of PAR signaling through receptor crosstalk
physiological and pathological relevance of these interactions, since this additional level of molecular cross-talk
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
The gross proceeds to Crinetics from the offering, before deducting the underwriting discounts and commissions
- Profiling Immune Cell and Platelet Transcriptomes
these receptors were also detected, highlighting the robustness of the assay and the potential for cross-validation
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Helen Su , et al. for their fantastic work on Germline mutations in a G protein identify signaling cross-talk research position GPCR Activation and Signaling Germline mutations in a G protein identify signaling cross-talk
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Heterodimerization when Expressed Heterologously in Saccharomyces cerevisiae The beta 2 adrenergic receptor cross-linked
- Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota..
Moreover, independent of glucose control or weight loss, the anti-inflammatory actions of GLP-1RAs require
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
dysregulated membrane trafficking, stability and phototransduction processes that lead to progressive loss
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
the so-called metabolic surgery whose beneficial effects are beyond dietary restrictions and weight loss
- Comparative study of neuropeptide signaling systems in Hemiptera
Independent secondary losses of the adipokinetic hormone/corazonin-related peptide receptor (ACP) and
- Addex Raises $10 Million In Equity Financing
Company agreed to sell 3,752,202 shares in the form of 625,367 American Depositary Shares (“ADSs”) at a gross
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
damage to healthy cells in the process, leading to side effects that can include pain, nausea, and hair loss
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
cholesterol-depleted cells (using statins) by fluorescence recovery after photobleaching (FRAP) and fluorescence loss
- GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation
pro-inflammatory properties in colonic macrophages through enhancing NLRP3 inflammasome activation, while the loss
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
Our results show that a mutation in the K101 residue leads to loss in thermal stability of the serotonin1A
- Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-retinal
Though most of these variants exhibit a loss of function, the molecular defects caused by these underlying
- Addex raises $4.2 million in equity financing
investor, to sell 3,300,000 shares in the form of 550,000 American Depositary Shares (“ADSs”) at a gross
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic diabetes insipidus "Loss-of-function
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
efficacy depends on which cells express the receptor Side effects are tied to where agonists bind Weight-loss
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
Nonetheless, we determined that mGlu5a internalization was not altered upon the loss of cPKCs or nPKCs
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
To test if this loss of PM localization could contribute to the mechanism of inhibition of αqQ209L by
- GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal...
The axonal degeneration that occurs before retinal ganglion neuronal loss is suggested to be involved
- Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembra
They often form homo- and heterodimers with allosteric cross-talk between receptor entities, which contributes









